(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TANNQUILYNNE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TANNQUILYNNE

ST13

US500000088167507

Class

5

Filing

88167507

Registration

6351061

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

05/19/2026

Trademark type

Word

Nice classes

5

Filing date

10/24/2018

Registration date

05/18/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/18/2021

Last transaction

05/19/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

03

Owner location

New Taipei City, TW

Examiner

VAGHANI, MAYUR C

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SyneuRx International (Taiwan) Corp.

Representatives

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Syrups for pharmaceutical purposes for the treatment of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes; Pharmaceutical preparations for the treatment of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes; Pharmaceutical preparations for the treatment and prevention of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Transdermal patches for use in the treatment of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes; Natural dietary supplements for the treatment of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes

Publications

History of USPTO decisions and trademark events.

38 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/18/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/18/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/02/2021

PUBO

PUBLISHED FOR OPPOSITION

03/02/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/10/2021

OTHE

CASE RETURNED TO EXAMINATION

12/31/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

12/31/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/29/2020

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

10/28/2020

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

10/28/2020

EX3G

SOU EXTENSION 3 GRANTED

10/28/2020

APET

ASSIGNED TO PETITION STAFF

10/18/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/18/2020

EXT3

SOU EXTENSION 3 FILED

09/10/2020

EEXT

SOU TEAS EXTENSION RECEIVED

09/10/2020

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

09/10/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/24/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/24/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/24/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/24/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/24/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/24/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/29/2020

EX2G

SOU EXTENSION 2 GRANTED

02/27/2020

EXT2

SOU EXTENSION 2 FILED

02/27/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/27/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/15/2019

EX1G

SOU EXTENSION 1 GRANTED

08/13/2019

EXT1

SOU EXTENSION 1 FILED

08/13/2019

EEXT

SOU TEAS EXTENSION RECEIVED

08/13/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/12/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/15/2019

PUBO

PUBLISHED FOR OPPOSITION

01/15/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/26/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/07/2018

DOCK

ASSIGNED TO EXAMINER

12/07/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/06/2018

NWAP

NEW APPLICATION ENTERED

10/27/2018

Continuous trademark protection

Get notified about every new filing that threatens TANNQUILYNNE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.